VION Biosciences Acquires BioAssay Systems

VION Biosciences Acquires Ansh Labs

August 29, 2024

Biotechnology

VION Biosciences, the life-science platform backed by Iron Path Capital, has acquired Ansh Labs, an immunoassay development and reagent manufacturer based in Houston, Texas. The add-on expands VION's diagnostics capabilities — adding GMP IVD manufacturing and ISO 13485 certification — and broadens the platform's product and service offerings for clinical diagnostics, research, and pharmaceutical development.

VION Biosciences Acquires Echelon Biosciences

August 22, 2024

Biotechnology

VION Biosciences, the life-science platform backed by Iron Path Capital, has acquired Salt Lake City-based Echelon Biosciences, a specialist supplier of lipid-based excipients and lipid nanoparticles. The add-on strengthens VION's capabilities in lipid synthesis and lipid nanoparticle technology to support mRNA and gene-therapy development and advances the platform toward drug manufacturing while keeping Echelon’s leadership and operations intact.

Pacific Biosciences Acquires Apton Biosystems

August 2, 2023

Biotechnology

Pacific Biosciences (PacBio) has entered into an agreement to acquire Apton Biosystems, a Pleasanton, California-based developer of high-throughput short-read sequencing instrumentation, to accelerate development of a next-generation, high-throughput short-read sequencer. The all-stock deal provides approximately $85 million upfront (≈6.3M shares) plus up to $25 million in additional consideration contingent on achieving $50 million in revenue, valuing the transaction at up to ~$110 million.

Biosynth Carbosynth Acquires Aalto Bio Reagents

May 26, 2022

Biotechnology

Biosynth Carbosynth, a Swiss life‑sciences supplier, has acquired Aalto Bio Reagents, a Dublin‑based developer and provider of biological materials for in‑vitro diagnostics (IVD) and vaccine development. The deal strengthens Biosynth’s IVD and vaccine product portfolio and expands its capabilities to serve diagnostics and vaccine development customers worldwide.

Iron Path Capital-backed VION Biosciences Acquires Aldon Corporation

August 7, 2023

Manufacturing

Iron Path Capital has formed VION Biosciences as a life-science roll-up platform and completed the acquisition of Aldon Corporation, a private-label manufacturer and distributor of lab chemicals headquartered in Avon, New York. Aldon will serve as VION’s inaugural platform investment to build a specialty chemicals and reagents business serving biopharma, molecular diagnostics and STEM education markets; Mark Thornton was named CEO of VION Biosciences.

Angus Chemical Company Acquires Expression Systems, LLC

November 9, 2022

Biotechnology

Angus Chemical Company (a PE-backed specialty ingredients manufacturer) has acquired Expression Systems, LLC, a Davis, California-based maker of cell culture media, baculovirus reagents, cell lines and related contract services. The acquisition expands Angus' life‑sciences capabilities into specialty cell culture media and strengthens its bioprocessing product and service offering; Achelous Partners served as exclusive advisor to Expression Systems.